Mangafodipir - an Intracellular Contrast Agent for Magnetic Resonance Imaging (MRI): Measuring Manganese Uptake Rate in Heart Failure Patients With Preserved Ejection Fraction (HFpEF) Patients.

NCT06731738 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction (HFPEF)

Interventions

DRUG: Gadoteric acid
DRUG: Mangafodipir trisodium injection

Sponsor

IC TARGETS AS